| ■ FDA Wants Drug Registrations, Listings Submitted Electronically | 06.08.24 |
| A new rule to automate all drug registration and listing in the United States was proposed Wednesday by the U.S. Food and Drug Administration. Under the proposal, all drug developers and manufacturers would be required to submit information electronically, rather than on paper. The Electronic Drug Registration and Listing System would make the entire list of drug products sold in the United States accessible electronically. Currently, part of that list, which includes 120,000 products, is kept on paper. "Having drug makers submit drug information electronically will help to keep an accurate, up-to-date inventory of drugs on the market. This will help us maintain more accurate information and make it easier for us to respond to drug emergencies such as recalls and drug shortages," U.S. Health and Human Services Secretary Mike Leavitt said in a prepared statement. Along with the FDA, the list is used by other government agencies, health-care providers and health-care payers. The list contains up-to-date information about specific drug formulations and manufacturers. |